Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B06 OTHER HEMATOLOGICAL AGENTS
B06A OTHER HEMATOLOGICAL AGENTS
B06AC Drugs used in hereditary angioedema
B06AC03 Ecallantide
D03931 Ecallantide (USAN/INN) <US>
USP drug classification [BR:br08302]
Immunological Agents
Angioedema Agents
Kallikrein Inhibitors
Ecallantide
D03931 Ecallantide (USAN/INN)
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Serine peptidases
Chymotrypsin family
KLKB1
D03931 Ecallantide (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D03931
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D03931